MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Motor control"

  • 2018 International Congress

    Internet of Things for Empowerment and Improved Treatment of Patients with Parkinson’s Disease

    L. Kani, M. Memedi, E. Kolkowska, G. Klein (Orebro, Sweden)

    Objective: This study aims to assess the effects of patient-directed feedback from remote symptom, medication, and disease activity monitoring on patient empowerment and treatment in…
  • 2018 International Congress

    Efficacy and safety of safinamide as a levodopa adjunct in patients with parkinson disease and motor fluctuations: A systematic review of randomized controlled trials

    S. Hussain, A. Najmi (New Delhi, India)

    Objective: To assess the efficacy and safety of safinamide as an add-on therapy to levodopa in Parkinson patients. Background: Long-term use of levodopa is associated…
  • 2018 International Congress

    Rotenone model of Parkinson’s disease: The dosing options in mice revisited

    M. Raza, N. Zehra, S. Malhi (Karachi, Pakistan)

    Objective: In the present study we have used various dosing protocols to induce the PD-like symptoms with the administration of rotenone in mice. Background: Parkinson's…
  • 2018 International Congress

    Can a novel digital pen system assist clinicians in the differential diagnosis of Parkinson’s disease?

    M. Agarwal, K. Vallely, R. Zietsma, W. Gray, R. Walker (Newcastle upon Tyne, United Kingdom)

    Objective: Our aim was to assess the utility of a novel electronic pen system in the differential diagnosis of PD at the time of referral.…
  • 2018 International Congress

    Efficacy of ND0612 for nocturnal problems and early morning OFF

    F. Stocchi, W. Poewe, T. Rachmilewitz Minei, S. Oren, R. Case, K. Kieburtz, C. Olanow (Rome, Italy)

    Objective: ND012 is a drug-device combination delivering liquid L-dopa/carbidopa (LD/CD) via continuous SC infusion. This secondary analysis evaluated the efficacy of 2 dosing regimens (R1:…
  • 2018 International Congress

    Effects of multi-session repetitive transcranial magnetic stimulation on performance of motor control and dynamics of spontaneous brain activity in multiple system atrophy

    Z. Liu, H.Z. Ma, X.M. Wang, Z. Wang, Y.Q. Wang, J.H. Zhou, T. Feng (Beijing, China)

    Objective: To explore the effectiveness of repetitive transcranial magnetic stimulation (rTMS) on performance of motor control and dynamics of spontaneous brain activity in multiple system…
  • 2018 International Congress

    A study on pre-adoption of a self-management application by Parkinson’s disease patients

    M. Memedi, J. Lindqvist, T. Tunedal, A. Duvåker (Örebro, Sweden)

    Objective: The aim of this paper is to investigate factors influencing acceptance by Parkinson's disease (PD) patients of a self-management application for an Internet of…
  • 2018 International Congress

    Effect of dual task as rehabilitation therapy in Parkinson’s disease in the UPDRS III

    C. Mejia (Lima, Peru)

    Objective: To determine the effect of the dual task used as Rehabilitation therapy in the UPDRS III of patients with Parkinson's disease. Background: Parkinson's disease…
  • 2018 International Congress

    Clinical indicators of advanced Parkinson’s disease: Evaluating diagnostic properties from retrospective analysis of multi-country, cross-sectional observational study

    P. Odin, Z. Pirtosek, R. Rodriguez, P. Martinez-Martin, D. Shah, P. Kandukuri, O. Koray, J. Zamudio, Y. Bao, Y. Jalundhwala, A. Antonini (Lund, Sweden)

    Objective: To measure the diagnostic properties of clinical indicators of advanced Parkinson Disease (APD). Background: Lack of consensus to define APD may lead to delay…
  • 2018 International Congress

    Voluntary suppression of Parkinson’s tremor

    R. Blakemore, M. MacAskill, D. Myall, T. Anderson (Christchurch, New Zealand)

    Objective: To provide the first detailed systematic investigation of the phenomenon of voluntary tremor suppression in Parkinson’s disease (PD). Background: We have observed in the…
  • « Previous Page
  • 1
  • …
  • 22
  • 23
  • 24
  • 25
  • 26
  • …
  • 40
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley